Discover 9 promising small molecule drug discovery companies that recently raised funding for their potentially breakthrough ...

Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L ...

A study of human tumor cells implanted in mice from the MacPherson Lab at Fred Hutch describes a new way to screen for the ...

Onctura commences randomized Phase I/II study in non-small cell lung cancer First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have ...

Current anticancer treatments essentially target the primary tumor cells that proliferate quickly, but do not effectively ...

A new class of molecules capable of killing the cancer cells that are refractory to standard treatments and responsible for recurrence has just been developed. This crucial advance in the fight ...

Chemistry professor Chris Chang’s lab studies the chemical biology of the elements, specifically examining the roles that ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative ...

Current anticancer treatments essentially target the primary tumour cells that proliferate quickly, but do not effectively ...

Collaboration combines Novo Nordisk’s scientific leadership in obesity and cardiometabolic diseases with Septerna’s expertise ...